|
WO2014027334A2
|
|
Oral pharmaceutical composition in the form of microspheres and preparation method
|
|
KR20150027797A
|
|
Novel solid forms of phosphodiesterase type 5 inhibitors
|
|
MX2012011288A
|
|
Combinations and compositions for treating obesity.
|
|
WO2012176155A1
|
|
Pharmaceutical composition for use against inflammation and pain
|
|
MX2011014042A
|
|
Antineuritic pharmaceutical combination and compositions.
|
|
MX2011005899A
|
|
Pharmaceutical composition with non-sedative antihistamine and combinations thereof.
|
|
MX2011004759A
|
|
Novel antibiotic solid forms.
|
|
MX2011002384A
|
|
Combined pharmaceutical composition for treating hyperplasia.
|
|
MX2010014484A
|
|
Combination and composition for treating obesity.
|
|
MX2010014153A
|
|
Controlled-release pharmaceutical tablet for oral administration.
|
|
MX2010011006A
|
|
New salt of a pyrimidin derivative.
|
|
MX2010006317A
|
|
Oral pharmaceutical composition with an antihistamine and decongestant.
|
|
MX2010004974A
|
|
Nonsteroideal anti-inflammatory and aminoacid composition.
|
|
MX2009001925A
|
|
Oral pharmaceutical composition for use in respiratory diseases.
|
|
MX2008011321A
|
|
Pharmaceutical composition for use in treating sexually transmitted infections.
|
|
MX2008011322A
|
|
Pharmaceutical composition for use in treating sexually transmitted infections.
|
|
MX2008007752A
|
|
Pharmaceutical composition in capsule with microspheres which comprises a salt of pantoprazol.
|
|
MX2008003230A
|
|
Oral pharmaceutical composition comprising a combination of a ketorolac salt and b-complex vitamins.
|
|
CA2670690A1
|
|
Pharmaceutical composition in the form of coated microspheres for the modified release of a muscle relaxant and an nsaid
|
|
MX2007008440A
|
|
Combined pharmaceutical composition.
|
